Citation Tools
PDFTreatment
Randomised controlled trial
Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Extending transdermal nicotine therapy from 8 to 24 weeks increases point-prevalence abstinence at 24 but not 52 weeks